Literature DB >> 16014304

Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits.

Shui-ping Zhao1, Zhi-hong Wu.   

Abstract

BACKGROUND: Leptin may play an important role in the development of atherosclerosis. We evaluated the effect of atorvastatin on leptin secretion in vivo and in vitro.
METHODS: Sixteen rabbits fed with high-cholesterol diet for 8 weeks were randomly divided into 2 groups: (1) high cholesterol diet for 6 weeks (n=8), and (2) the same cholesterol diet plus atorvastatin (2.5 mg/kg/day) for 6 weeks (n=8). A control group (n=5) was fed with normal diet for 14 weeks. Subcutaneous adipose was collected for RNA analysis. The direct effect of atorvastatin on leptin release was assayed in primary rabbit adipocytes. Leptin levels in serum and adipocytes culture supernatant were measured by ELISA. RT-PCR was used to evaluate leptin mRNA expressions in adipose and adipocytes.
RESULTS: Compared with control group, rabbits fed with high cholesterol diet showed higher levels of serum total cholesterol, LDL cholesterol and leptin, all of which were significantly reduced by atorvastatin treatment. Leptin mRNA expression of adipose was significant lower in rabbits treated with atorvastatin than those fed with high cholesterol diet continuously (0.81+/-0.31 vs. 1.23+/-0.36, P<0.05). Atorvastatin dose-dependently inhibited leptin secretion and mRNA expression in cultured adipocytes.
CONCLUSION: Atorvastatin can inhibit leptin release and mRNA expression, and reduces serum leptin level in hypercholesterolemic rabbits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014304     DOI: 10.1016/j.cccn.2005.04.021

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

Review 1.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

2.  Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease.

Authors:  Yuji Takahashi; Mamoru Satoh; Tsuyoshi Tabuchi; Motoyuki Nakamura
Journal:  Heart Vessels       Date:  2011-06-04       Impact factor: 2.037

3.  Pharmacological effects of lipid-lowering drugs on circulating adipokines.

Authors:  Desiree Wanders; Eric P Plaisance; Robert L Judd
Journal:  World J Diabetes       Date:  2010-09-15

4.  Role of leptin in atherogenesis.

Authors:  Laxman Dubey; Zeng Hesong
Journal:  Exp Clin Cardiol       Date:  2006

5.  Assessment of Various Biochemical Parameters and BMI in Patients with Skin Tags.

Authors:  Vinod Wali; Vishal V Wali
Journal:  J Clin Diagn Res       Date:  2016-01-01

6.  The alpha linolenic acid content of flaxseed is associated with an induction of adipose leptin expression.

Authors:  Richelle S McCullough; Andrea L Edel; Chantal M C Bassett; Renée K Lavallée; Elena Dibrov; David P Blackwood; Bradley P Ander; Grant N Pierce
Journal:  Lipids       Date:  2011-10-27       Impact factor: 1.880

7.  Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes.

Authors:  Sayer I Al-Azzam; Asem M Alkhateeb; Karem H Alzoubi; Raya N Alzayadeen; Mera A Ababneh; Omar F Khabour
Journal:  Exp Ther Med       Date:  2013-10-15       Impact factor: 2.447

Review 8.  Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.

Authors:  Sofia Dias; Sílvia Paredes; Laura Ribeiro
Journal:  Int J Endocrinol       Date:  2018-01-17       Impact factor: 3.257

9.  Serum leptin, atherogenic lipids and glucose levels in patients with skin tags.

Authors:  Canan Gorpelioglu; Emel Erdal; Yasemin Ardicoglu; Bahattin Adam; Evren Sarifakioglu
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  Sitagliptin ameliorates the progression of atherosclerosis via down regulation of the inflammatory and oxidative pathways.

Authors:  Sahar A Majeed; Najah R Hadi; Ahmed M Al Mudhafar; Hussein A Al-Janabi
Journal:  SAGE Open Med       Date:  2013-09-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.